Drug archive
Antifibrinolytic Agents (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antifibrinolytic
- Antihemorrhagic - Aminocaproic Acid; Tranexamic Acid
Description
Antifibrinolytic (an-tee-fye-bri-noh-LIT-ik) agents are used to treat serious bleeding, especially when the bleeding occurs after dental surgery (particularly in patients with hemophilia) or certain other kinds of surgery. These medicines are also sometimes given before an operation to prevent serious bleeding in patients with medical problems that increase the chance of serious bleeding.
Antifibrinolytic agents may also be used for other conditions as determined by your doctor.
Antifibrinolytic agents are available only with your doctor's prescription, in the following dosage forms:
-
Aminocaproic acid
- Syrup (U.S. and Canada)
- Tablets (U.S. and Canada)
-
Tranexamic acid
- Tablets (U.S. and Canada)
-
Aminocaproic acid
- Injection (U.S. and Canada)
-
Tranexamic acid
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Amicar 1
- Cyklokapron 2
In Canada -
- Amicar 1
- Cyklokapron 2
Another commonly used name for aminocaproic acid is epsilon-aminocaproic acid .
| This information applies to the following medicines: | ||
| 1. | Aminocaproic Acid (a-mee-noe-ka-PROE-ikASS-id)‡ | |
| 2. | Tranexamic Acid (tran-ex-AM-ik ASS-id) | |
| ‡ Generic name product may be available in the U.S. | ||